Swedbank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.8M Sell
792,187
-4,550
-0.6% -$265K 0.05% 238
2025
Q4
$47.4M Buy
796,737
+329,794
+71% +$18M 0.05% 232
2025
Q3
$25.3M Buy
466,943
+35,000
+8% +$2M 0.03% 344
2025
Q2
$23.7M Buy
431,943
+2,100
+0.5% +$124K 0.03% 333
2025
Q1
$30.4M Sell
429,843
-2,279
-0.5% -$153K 0.04% 282
2024
Q4
$28.4M Buy
432,122
+43,593
+11% +$2.92M 0.03% 289
2024
Q3
$27.3M Buy
388,529
+100,000
+35% +$8.36M 0.03% 286
2024
Q2
$23.8M Sell
288,529
-7,600
-3% -$633K 0.03% 290
2024
Q1
$25.9M Sell
296,129
-170,100
-36% -$15.2M 0.23% 148
2023
Q4
$45M Sell
466,229
-40,800
-8% -$3.61M 0.07% 194
2023
Q3
$44.9M Hold
507,029
0.08% 185
2023
Q2
$43.9M Hold
507,029
0.08% 200
2023
Q1
$49.3M Buy
507,029
+59,200
+13% +$6.14M 0.1% 173
2022
Q4
$46.3M Buy
447,829
+26,900
+6% +$2.53M 0.1% 185
2022
Q3
$35.7M Sell
420,929
-108,190
-20% -$9.63M 0.09% 198
2022
Q2
$43.8M Buy
529,119
+24,661
+5% +$1.96M 0.1% 182
2022
Q1
$38.9M Buy
504,458
+183,493
+57% +$15.4M 0.07% 226
2021
Q4
$28.6M Sell
320,965
-15,058
-4% -$1.24M 0.05% 278
2021
Q3
$26M Buy
336,023
+192,144
+134% +$15.2M 0.05% 289
2021
Q2
$12M Hold
143,879
0.02% 446
2021
Q1
$10.9M Buy
+143,879
New +$11.8M 0.02% 451

Other funds holding BMRN